Pfizer (PFE) Misses Q4 EPS by 6c, Raises FY21 EPS Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.72 -1.44%
EPS Growth %: -12.8%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -12.8%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q4 EPS of $0.42, $0.06 worse than the analyst estimate of $0.48. Revenue for the quarter came in at $11.7 billion versus the consensus estimate of $11.43 billion.
GUIDANCE:
Pfizer sees FY2021 EPS of $3.10-$3.20, versus the consensus of $3.19. Pfizer sees FY2021 revenue of $59.4-61.4 billion, versus the consensus of $56.72 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Enanta Pharma loses appeal in Pfizer Paxlovid patent case
- Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
